Review





Similar Products

90
National Centre for Cell Science pancreatic β-cell line mouse insulinoma 6 (min6)
Pancreatic β Cell Line Mouse Insulinoma 6 (Min6), supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pancreatic β-cell line mouse insulinoma 6 (min6)/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
pancreatic β-cell line mouse insulinoma 6 (min6) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science mouse insulinoma cell line min6
Mouse Insulinoma Cell Line Min6, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse insulinoma cell line min6/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
mouse insulinoma cell line min6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AddexBio Inc mouse insulinoma cell line min6
( A ) Schematic design and 3D printer machine pathing G-code of a dual parallel channel multi-material CHIPS with pancreatic vascular cell bioink <t>(MIN6,</t> HUVEC, and MSC) regions surrounding both sides of the channels. ( B ) Pancreatic CHIPS FRESH printed and visualized via bright-field stereomicroscope (inset) and 3D confocal fluorescence imaging of the optically cleared pancreatic scaffold after 12 days of static culture. ( C ) XY midplane view from confocal fluorescence image of the 12-day statically cultured pancreatic CHIPS following 3D vascular network segmentation for quantification of network diameter and density within the migratory zones. ( D ) Example confocal fluorescence images revealing additional cell migration into the acellular regions of the CHIPS beneath the cellular regions guided by the printed collagen filaments. ( E ) XY midplane projection view from 3D confocal fluorescence imaging of the optically cleared 12-day VAPOR perfused pancreatic CHIPS. ( F ) Graphic illustration and example ROIs depicting evidence of early <t>MIN6</t> pancreatic bud and microlumen formation with actin (green) and insulin (magenta) fluorescence images from ROIs 2 and 3 in (E). ( G ) Graphic illustration and quantification for insulin secretion ELISA assay from 1.5-hour glucose-stimulated [ratio of high glucose (HG) to low glucose (LG)] insulin secretion experiment between 12-day static and perfusion cultured pancreatic CHIPS (means ± SD; ** P < 0.01 for N = 3 static tissues; N = 2 perfused tissues, unpaired t test).
Mouse Insulinoma Cell Line Min6, supplied by AddexBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse insulinoma cell line min6/product/AddexBio Inc
Average 90 stars, based on 1 article reviews
mouse insulinoma cell line min6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science mouse insulinoma pancreatic β-cells min6
( A ) Schematic design and 3D printer machine pathing G-code of a dual parallel channel multi-material CHIPS with pancreatic vascular cell bioink <t>(MIN6,</t> HUVEC, and MSC) regions surrounding both sides of the channels. ( B ) Pancreatic CHIPS FRESH printed and visualized via bright-field stereomicroscope (inset) and 3D confocal fluorescence imaging of the optically cleared pancreatic scaffold after 12 days of static culture. ( C ) XY midplane view from confocal fluorescence image of the 12-day statically cultured pancreatic CHIPS following 3D vascular network segmentation for quantification of network diameter and density within the migratory zones. ( D ) Example confocal fluorescence images revealing additional cell migration into the acellular regions of the CHIPS beneath the cellular regions guided by the printed collagen filaments. ( E ) XY midplane projection view from 3D confocal fluorescence imaging of the optically cleared 12-day VAPOR perfused pancreatic CHIPS. ( F ) Graphic illustration and example ROIs depicting evidence of early <t>MIN6</t> pancreatic bud and microlumen formation with actin (green) and insulin (magenta) fluorescence images from ROIs 2 and 3 in (E). ( G ) Graphic illustration and quantification for insulin secretion ELISA assay from 1.5-hour glucose-stimulated [ratio of high glucose (HG) to low glucose (LG)] insulin secretion experiment between 12-day static and perfusion cultured pancreatic CHIPS (means ± SD; ** P < 0.01 for N = 3 static tissues; N = 2 perfused tissues, unpaired t test).
Mouse Insulinoma Pancreatic β Cells Min6, supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse insulinoma pancreatic β-cells min6/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
mouse insulinoma pancreatic β-cells min6 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
AddexBio Inc min6 mouse insulinoma β-cells
( A ) Optiprep workflow : <t>MIN6</t> post-nuclear supernatant is loaded atop 5 fixed concentrations of Optiprep and ultra-centrifuged for 75min at 100,000g. ( B ) Representative example of visible subcellular fractionation distribution after ultra-centrifugation. ( C ) Representative quantification of insulin enrichment from 16 fractions of Optiprep by insulin ELISA ( D ) Western blot analysis of pro- and insulin enrichment of Optiprep fractions, as well as marker proteins for subcellular components of beta-cells. ( E ) Percoll workflow : Fractions 11 and 12 from Optiprep gradients following insulin enrichment analysis are loaded on top of 27% Percoll and ultra-centrifuged for 60min at 35,000g. ( F ) SDS-PAGE analysis of insulin enrichment of Percoll fractionation, as well as marker proteins for subcellular components of MIN6 beta-cells.
Min6 Mouse Insulinoma β Cells, supplied by AddexBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/min6 mouse insulinoma β-cells/product/AddexBio Inc
Average 90 stars, based on 1 article reviews
min6 mouse insulinoma β-cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
National Centre for Cell Science min6 cells (mouse insulinoma cell line)
( A ) Optiprep workflow : <t>MIN6</t> post-nuclear supernatant is loaded atop 5 fixed concentrations of Optiprep and ultra-centrifuged for 75min at 100,000g. ( B ) Representative example of visible subcellular fractionation distribution after ultra-centrifugation. ( C ) Representative quantification of insulin enrichment from 16 fractions of Optiprep by insulin ELISA ( D ) Western blot analysis of pro- and insulin enrichment of Optiprep fractions, as well as marker proteins for subcellular components of beta-cells. ( E ) Percoll workflow : Fractions 11 and 12 from Optiprep gradients following insulin enrichment analysis are loaded on top of 27% Percoll and ultra-centrifuged for 60min at 35,000g. ( F ) SDS-PAGE analysis of insulin enrichment of Percoll fractionation, as well as marker proteins for subcellular components of MIN6 beta-cells.
Min6 Cells (Mouse Insulinoma Cell Line), supplied by National Centre for Cell Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/min6 cells (mouse insulinoma cell line)/product/National Centre for Cell Science
Average 90 stars, based on 1 article reviews
min6 cells (mouse insulinoma cell line) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Procell Inc mouse insulinoma 6 (min6) cells cl-0674
( A ) Optiprep workflow : <t>MIN6</t> post-nuclear supernatant is loaded atop 5 fixed concentrations of Optiprep and ultra-centrifuged for 75min at 100,000g. ( B ) Representative example of visible subcellular fractionation distribution after ultra-centrifugation. ( C ) Representative quantification of insulin enrichment from 16 fractions of Optiprep by insulin ELISA ( D ) Western blot analysis of pro- and insulin enrichment of Optiprep fractions, as well as marker proteins for subcellular components of beta-cells. ( E ) Percoll workflow : Fractions 11 and 12 from Optiprep gradients following insulin enrichment analysis are loaded on top of 27% Percoll and ultra-centrifuged for 60min at 35,000g. ( F ) SDS-PAGE analysis of insulin enrichment of Percoll fractionation, as well as marker proteins for subcellular components of MIN6 beta-cells.
Mouse Insulinoma 6 (Min6) Cells Cl 0674, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse insulinoma 6 (min6) cells cl-0674/product/Procell Inc
Average 90 stars, based on 1 article reviews
mouse insulinoma 6 (min6) cells cl-0674 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic design and 3D printer machine pathing G-code of a dual parallel channel multi-material CHIPS with pancreatic vascular cell bioink (MIN6, HUVEC, and MSC) regions surrounding both sides of the channels. ( B ) Pancreatic CHIPS FRESH printed and visualized via bright-field stereomicroscope (inset) and 3D confocal fluorescence imaging of the optically cleared pancreatic scaffold after 12 days of static culture. ( C ) XY midplane view from confocal fluorescence image of the 12-day statically cultured pancreatic CHIPS following 3D vascular network segmentation for quantification of network diameter and density within the migratory zones. ( D ) Example confocal fluorescence images revealing additional cell migration into the acellular regions of the CHIPS beneath the cellular regions guided by the printed collagen filaments. ( E ) XY midplane projection view from 3D confocal fluorescence imaging of the optically cleared 12-day VAPOR perfused pancreatic CHIPS. ( F ) Graphic illustration and example ROIs depicting evidence of early MIN6 pancreatic bud and microlumen formation with actin (green) and insulin (magenta) fluorescence images from ROIs 2 and 3 in (E). ( G ) Graphic illustration and quantification for insulin secretion ELISA assay from 1.5-hour glucose-stimulated [ratio of high glucose (HG) to low glucose (LG)] insulin secretion experiment between 12-day static and perfusion cultured pancreatic CHIPS (means ± SD; ** P < 0.01 for N = 3 static tissues; N = 2 perfused tissues, unpaired t test).

Journal: Science Advances

Article Title: 3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems

doi: 10.1126/sciadv.adu5905

Figure Lengend Snippet: ( A ) Schematic design and 3D printer machine pathing G-code of a dual parallel channel multi-material CHIPS with pancreatic vascular cell bioink (MIN6, HUVEC, and MSC) regions surrounding both sides of the channels. ( B ) Pancreatic CHIPS FRESH printed and visualized via bright-field stereomicroscope (inset) and 3D confocal fluorescence imaging of the optically cleared pancreatic scaffold after 12 days of static culture. ( C ) XY midplane view from confocal fluorescence image of the 12-day statically cultured pancreatic CHIPS following 3D vascular network segmentation for quantification of network diameter and density within the migratory zones. ( D ) Example confocal fluorescence images revealing additional cell migration into the acellular regions of the CHIPS beneath the cellular regions guided by the printed collagen filaments. ( E ) XY midplane projection view from 3D confocal fluorescence imaging of the optically cleared 12-day VAPOR perfused pancreatic CHIPS. ( F ) Graphic illustration and example ROIs depicting evidence of early MIN6 pancreatic bud and microlumen formation with actin (green) and insulin (magenta) fluorescence images from ROIs 2 and 3 in (E). ( G ) Graphic illustration and quantification for insulin secretion ELISA assay from 1.5-hour glucose-stimulated [ratio of high glucose (HG) to low glucose (LG)] insulin secretion experiment between 12-day static and perfusion cultured pancreatic CHIPS (means ± SD; ** P < 0.01 for N = 3 static tissues; N = 2 perfused tissues, unpaired t test).

Article Snippet: MIN6 (mouse insulinoma cell line) (Addexbio, C0018008) were cultured in high-glucose Dulbecco’s modified Eagle’s medium (DMEM, Gibco, 11-965-092) with 15% fetal bovine serum (v/v), 2 mM sodium pyruvate, 20 mM Hepes, and 0.05 mM β-mercaptoethanol, using passages 9 to 15.

Techniques: Fluorescence, Imaging, Cell Culture, Migration, Enzyme-linked Immunosorbent Assay

( A ) Optiprep workflow : MIN6 post-nuclear supernatant is loaded atop 5 fixed concentrations of Optiprep and ultra-centrifuged for 75min at 100,000g. ( B ) Representative example of visible subcellular fractionation distribution after ultra-centrifugation. ( C ) Representative quantification of insulin enrichment from 16 fractions of Optiprep by insulin ELISA ( D ) Western blot analysis of pro- and insulin enrichment of Optiprep fractions, as well as marker proteins for subcellular components of beta-cells. ( E ) Percoll workflow : Fractions 11 and 12 from Optiprep gradients following insulin enrichment analysis are loaded on top of 27% Percoll and ultra-centrifuged for 60min at 35,000g. ( F ) SDS-PAGE analysis of insulin enrichment of Percoll fractionation, as well as marker proteins for subcellular components of MIN6 beta-cells.

Journal: bioRxiv

Article Title: Optimised proteomic analysis of insulin granules from MIN6 β-cells identifies Scamp3, a novel regulator of insulin secretion and content

doi: 10.1101/2024.04.23.590838

Figure Lengend Snippet: ( A ) Optiprep workflow : MIN6 post-nuclear supernatant is loaded atop 5 fixed concentrations of Optiprep and ultra-centrifuged for 75min at 100,000g. ( B ) Representative example of visible subcellular fractionation distribution after ultra-centrifugation. ( C ) Representative quantification of insulin enrichment from 16 fractions of Optiprep by insulin ELISA ( D ) Western blot analysis of pro- and insulin enrichment of Optiprep fractions, as well as marker proteins for subcellular components of beta-cells. ( E ) Percoll workflow : Fractions 11 and 12 from Optiprep gradients following insulin enrichment analysis are loaded on top of 27% Percoll and ultra-centrifuged for 60min at 35,000g. ( F ) SDS-PAGE analysis of insulin enrichment of Percoll fractionation, as well as marker proteins for subcellular components of MIN6 beta-cells.

Article Snippet: The MIN6 mouse insulinoma β-cells were purchased from AddexBio TM and cultured in standard culture media as stated previously .

Techniques: Fractionation, Centrifugation, Enzyme-linked Immunosorbent Assay, Western Blot, Marker, SDS Page

( A ) Confocal fluorescence imaging of MIN6 cells labelled with anti-insulin co-stained with anti-ZIP8 (n = 3), anti-Synaptophysin (n = 3), anti-Synaptotagmin-13 (n = 4), anti-Syntaxin-7 (n = 3), anti-Scamp3 (n = 3) and anti-Chromogranin A (n = 3). Enrichment profile of candidate proteins across 12 fractions from LC-MS/MS analysis. ( B ) Quantification of colocalization of candidate proteins with insulin using Pearson’s correlation coefficient (with Costes’ automatic thresholds). Filled dots in purple represent the number of experiments (Run #) these proteins appear within pRoloc analyses. ( C ) Confocal fluorescence imaging of human islets labelled with anti-insulin, co-stained with anti-synaptophysin (n = 1), anti-synaptotagmin-13 (n = 1), anti-syntaxin7 (n = 1) and anti-Scamp3 (n = 1). ( D ) Quantification of colocalization of candidate proteins with insulin from individual islets from a single human non-type 2 diabetic donor for each protein using Pearson’s correlation coefficient (with Costes’ automatic thresholds). All error bars represent standard error of the mean (+-S.E.M.)

Journal: bioRxiv

Article Title: Optimised proteomic analysis of insulin granules from MIN6 β-cells identifies Scamp3, a novel regulator of insulin secretion and content

doi: 10.1101/2024.04.23.590838

Figure Lengend Snippet: ( A ) Confocal fluorescence imaging of MIN6 cells labelled with anti-insulin co-stained with anti-ZIP8 (n = 3), anti-Synaptophysin (n = 3), anti-Synaptotagmin-13 (n = 4), anti-Syntaxin-7 (n = 3), anti-Scamp3 (n = 3) and anti-Chromogranin A (n = 3). Enrichment profile of candidate proteins across 12 fractions from LC-MS/MS analysis. ( B ) Quantification of colocalization of candidate proteins with insulin using Pearson’s correlation coefficient (with Costes’ automatic thresholds). Filled dots in purple represent the number of experiments (Run #) these proteins appear within pRoloc analyses. ( C ) Confocal fluorescence imaging of human islets labelled with anti-insulin, co-stained with anti-synaptophysin (n = 1), anti-synaptotagmin-13 (n = 1), anti-syntaxin7 (n = 1) and anti-Scamp3 (n = 1). ( D ) Quantification of colocalization of candidate proteins with insulin from individual islets from a single human non-type 2 diabetic donor for each protein using Pearson’s correlation coefficient (with Costes’ automatic thresholds). All error bars represent standard error of the mean (+-S.E.M.)

Article Snippet: The MIN6 mouse insulinoma β-cells were purchased from AddexBio TM and cultured in standard culture media as stated previously .

Techniques: Fluorescence, Imaging, Staining, Liquid Chromatography with Mass Spectroscopy

( A ) SDS-PAGE analysis of INS-1 cell lysates 48 hours post transfection with a control non-targeting siRNA and two unique siRNAs specific to Scamp3 (siScamp3#1 and siScamp3#2) in 3 experimental replicates together (n = 3). ( B ) Densitometry quantification of knockdown efficiency of Scamp3 48 hours post transfection (n = 3) normalized to GAPDH. ( C ) Insulin SDS-PAGE analysis of INS-1 cell lysates 48 hours post transfection of control and siRNA KD INS-1 cells. ( D ) Densitometry quantification of insulin content in control and siRNA KD INS-1 cells (n = 3) normalized to beta-actin. ( E ) Glucose-stimulated insulin secretion assay: insulin concentration after basal (2.8 mM) and stimulation (16.7 mM) glucose conditions from INS-1 control and siRNA KD cells measured by insulin HTRF (n = 8). ( F ) Fold-change of basal to stimulation glucose conditions from E (n = 8). ( G ) Representative confocal fluorescence imaging of human non-type 2 diabetic (n = 5) and type 2 diabetic (n = 5) islets labelled with anti-insulin and co-stained with Scamp3. ( H ) Mean fluorescence intensity of Scamp3 within β-cells of human non-type 2 diabetic and type 2 diabetic islets ( I ) Quantification of colocalization of Scamp3 with insulin using Pearson’s correlation coefficient (with Costes’ automatic thresholds) in human non-type 2 diabetic and type 2 diabetic islets. All error bars represent standard error of the mean (+-S.E.M.)

Journal: bioRxiv

Article Title: Optimised proteomic analysis of insulin granules from MIN6 β-cells identifies Scamp3, a novel regulator of insulin secretion and content

doi: 10.1101/2024.04.23.590838

Figure Lengend Snippet: ( A ) SDS-PAGE analysis of INS-1 cell lysates 48 hours post transfection with a control non-targeting siRNA and two unique siRNAs specific to Scamp3 (siScamp3#1 and siScamp3#2) in 3 experimental replicates together (n = 3). ( B ) Densitometry quantification of knockdown efficiency of Scamp3 48 hours post transfection (n = 3) normalized to GAPDH. ( C ) Insulin SDS-PAGE analysis of INS-1 cell lysates 48 hours post transfection of control and siRNA KD INS-1 cells. ( D ) Densitometry quantification of insulin content in control and siRNA KD INS-1 cells (n = 3) normalized to beta-actin. ( E ) Glucose-stimulated insulin secretion assay: insulin concentration after basal (2.8 mM) and stimulation (16.7 mM) glucose conditions from INS-1 control and siRNA KD cells measured by insulin HTRF (n = 8). ( F ) Fold-change of basal to stimulation glucose conditions from E (n = 8). ( G ) Representative confocal fluorescence imaging of human non-type 2 diabetic (n = 5) and type 2 diabetic (n = 5) islets labelled with anti-insulin and co-stained with Scamp3. ( H ) Mean fluorescence intensity of Scamp3 within β-cells of human non-type 2 diabetic and type 2 diabetic islets ( I ) Quantification of colocalization of Scamp3 with insulin using Pearson’s correlation coefficient (with Costes’ automatic thresholds) in human non-type 2 diabetic and type 2 diabetic islets. All error bars represent standard error of the mean (+-S.E.M.)

Article Snippet: The MIN6 mouse insulinoma β-cells were purchased from AddexBio TM and cultured in standard culture media as stated previously .

Techniques: SDS Page, Transfection, Concentration Assay, Fluorescence, Imaging, Staining